Depomed, Boehringer Ingelheim deal

DEPO will use its Gastric Retention technology to develop a controlled-release formulation of an undisclosed compound for Boehringer's Boehringer Ingelheim Pharmaceuticals Inc. subsidiary (Ridgefield,...